Back to search
FDAFDA · Food and drugs·Recall number Z-1486-2017

Merge Cardio software.

Published March 29, 2017 · Recall initiated: April 4, 2016

Summary

FDA records medical device Class II recall Z-1486-2017, published March 29, 2017 and initiated April 4, 2016. Recalling firm: Merge Healthcare, Inc.; Status: Terminated; Reported quantity: 217 sites potentially have the affected versions; Lot: Versions 9.0; 9.0.1; 9.0.2; 9.0.3; 9.0.4; 9.0.5; 9.0.6; 9.0.7, 9.0.8, 9.0.9, 10.0, 10.0.1, 10.1, 10.1.1, and 10.1.2. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cardio study list does not show STAT studies without refreshing.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Merge Healthcare, Inc.
Distributor
Distribution was nationwide to medical facilities. There was also military distribution. There was no foreign/government distribution.
Lot
Versions 9.0; 9.0.1; 9.0.2; 9.0.3; 9.0.4; 9.0.5; 9.0.6; 9.0.7, 9.0.8, 9.0.9, 10.0, 10.0.1, 10.1, 10.1.1, and 10.1.2.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Merge Cardio software. recalled?

Yes. FDA published recall Z-1486-2017 on March 29, 2017. Reported hazard: Cardio study list does not show STAT studies without refreshing.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit